新天药业
(002873)
| 流通市值：23.27亿 | | | 总市值：23.70亿 |
| 流通股本：2.40亿 | | | 总股本：2.44亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 178,610,160.01 | 749,720,071.32 | 558,633,030.72 | 358,286,117.72 |
| 营业收入 | 178,610,160.01 | 749,720,071.32 | 558,633,030.72 | 358,286,117.72 |
| 二、营业总成本 | 174,084,468.5 | 744,175,673.38 | 545,335,763.62 | 354,583,092.36 |
| 营业成本 | 49,127,083.34 | 213,074,541.32 | 157,578,252.33 | 102,030,526.06 |
| 税金及附加 | 5,030,854.44 | 14,190,460.81 | 11,860,272.08 | 6,624,132.2 |
| 销售费用 | 76,866,163.79 | 328,797,168.63 | 239,774,794.96 | 159,123,976.03 |
| 管理费用 | 29,310,706.43 | 127,908,162.42 | 91,534,094.33 | 58,149,889.18 |
| 研发费用 | 9,304,365.07 | 42,554,033.91 | 32,148,963.09 | 20,118,256.16 |
| 财务费用 | 4,445,295.43 | 17,651,306.29 | 12,439,386.83 | 8,536,312.73 |
| 其中:利息费用 | 4,499,983.7 | 17,759,705.67 | 12,533,228.55 | 8,571,980.17 |
| 其中:利息收入 | 95,663.4 | 416,217.25 | 291,944.29 | 207,683.34 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -7,100.52 | -21,808.74 | -16,229.76 | -22,823.1 |
| 加:投资收益 | - | 6,728.87 | 6,728.87 | 6,728.87 |
| 资产处置收益 | - | -781,861.48 | -1,017,599.78 | -845,407.25 |
| 资产减值损失(新) | -1,089,608.94 | -3,597,009.59 | -2,218,972.18 | -1,462,610.93 |
| 信用减值损失(新) | 600,117.48 | 2,000,257.91 | 1,363,278.1 | 667,649.09 |
| 其他收益 | 1,199,945.85 | 6,920,327.06 | 5,524,605.46 | 4,500,513.31 |
| 四、营业利润 | 5,229,045.38 | 10,071,031.97 | 16,939,077.81 | 6,547,075.35 |
| 加:营业外收入 | 31,780.55 | 58,531.12 | 57,136.75 | 59,284.17 |
| 减:营业外支出 | 15,376.86 | 360,106.48 | 324,657.17 | 336,668.5 |
| 五、利润总额 | 5,245,449.07 | 9,769,456.61 | 16,671,557.39 | 6,269,691.02 |
| 减:所得税费用 | 1,750,275.95 | 657,980.8 | 490,617.22 | 503,612.67 |
| 六、净利润 | 3,495,173.12 | 9,111,475.81 | 16,180,940.17 | 5,766,078.35 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 3,495,173.12 | 9,111,475.81 | 16,180,940.17 | 5,766,078.35 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 3,495,173.12 | 9,111,475.81 | 16,180,940.17 | 5,766,078.35 |
| 扣除非经常损益后的净利润 | 3,009,913.8 | 5,335,961.65 | 13,554,547.75 | 3,579,494.68 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | 0.04 | 0.07 | 0.02 |
| (二)稀释每股收益 | 0.01 | 0.04 | 0.07 | 0.02 |
| 八、其他综合收益 | - | 66,535,046.25 | 66,535,046.25 | - |
| 归属于母公司股东的其他综合收益 | - | 66,535,046.25 | 66,535,046.25 | - |
| 九、综合收益总额 | 3,495,173.12 | 75,646,522.06 | 82,715,986.42 | 5,766,078.35 |
| 归属于母公司股东的综合收益总额 | 3,495,173.12 | 75,646,522.06 | 82,715,986.42 | 5,766,078.35 |
| 公告日期 | 2026-04-30 | 2026-03-31 | 2025-10-31 | 2025-07-31 |
| 审计意见(境内) | | 标准无保留意见 | | |